Institution statistics

BOEHRINGER INGELHEIM PHARMA GMBH &CO KG -  

Ranking results:

Past rankings:
2019
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:> 1000
Total Number of Projects:300-400
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 35
As coordinator: 2
As participant: 33
Sole participant: 0
Coordinator / Participant Ratio: 0.06*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 27.935.000 0 1
2019 0 68.205.073 516.996 9
2018 0 15.942.861 0 2
2017 0 55.675.195 0 6
2016 0 33.556.083 463.820 4
2013 0 6.485.847 0 1
2012 0 11.174.600 307.640 2
2010 0 9.834.779 0 3
2009 0 2.419.227 241.923 1
2008 0 16.953.914 974.413 2
2007 0 3.702.750 217.809 1
2005 0 11.998.527 285.679 1
2004 4.088.384 0 340.699 1
2002 2.060.873 0 343.479 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
NOVARTIS PHARMA9
JANSSEN PHARMACEUTICA NV7
PFIZER LIMITED7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V6
BAYER5
ELI LILLY AND COMPANY LIMITED5
UNIVERSITAET BERN5
ASTRAZENECA AB4
EUROPEAN MOLECULAR BIOLOGY LABORATORY4
F HOFFMANNLA ROCHE4
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT4
INSTITUT DE RECHERCHES SERVIER4
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN4
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT4
UCB BIOPHARMA4
UNIVERSITAT WIEN4
UNIVERSITE DU LUXEMBOURG4
UNIVERSITY OF DUNDEE4
ABBVIE INC3
ASTRAZENECA3
BAYER AKTIENGESELLSCHAFT3
EBERHARD KARLS UNIVERSITAET TUEBINGEN3
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH3
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM3
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE3
LEIDS UNIVERSITAIR MEDISCH CENTRUM3
MEDIZINISCHE UNIVERSITAET WIEN3
NOVO NORDISK3
SANOFIAVENTIS3
SANOFIAVENTIS DEUTSCHLAND3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITAETSMEDIZIN DER JOHANNES GUTENBERG UNIVERSITAET MAINZ3
UNIVERSITEIT LEIDEN3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF HELSINKI3
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM2
ACADEMISCH ZIEKENHUIS GRONINGEN2
ALLERGAN LIMITED2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
ASTELLAS PHARMA EUROPE BV2
CERTARA UK LIMITED2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE2
JDRF INTERNATIONAL2
KAROLINSKA INSTITUTE2
LUNDS UNIVERSITET2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
MERCK SHARP & DOHME CORP2
MOLECULAR NETWORKS GMBH COMPUTERCHEMIE2
ORION OYJ2
SIB INSTITUT SUISSE DE BIOINFORMATIQUE2
STICHTING KATHOLIEKE UNIVERSITEIT2
STICHTING LYGATURE2
SYDDANSK UNIVERSITET2
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL2
TAKEDA DEVELOPMENT CENTRE EUROPE2
TECHNISCHE UNIVERSITAET MUENCHEN2
THE UNIVERSITY OF MANCHESTER2
TRANSGENE2
UNIVERSITAETSKLINIKUM AACHEN2
UNIVERSITAETSKLINIKUM FREIBURG2
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF2
UNIVERSITAETSKLINIKUM WUERZBURG KLINIKUM DER BAYERISCHEN JULIUSMAXIMILIANSUNIVERSITAT2
UNIVERSITAIR MEDISCH CENTRUM UTRECHT2
UNIVERSITEIT TWENTE2
UNIVERSITY OF BRISTOL2
UNIVERSITY OF OSLO2
UNIVERSITY OF TAMPERE2
2M ENGINEERING LIMITED1
AB ENZYMES1
ABBVIE DEUTSCHLAND GMBH & CO KG1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
ACADEMISCH ZIEKENHUIS LEIDEN1
ACIB1
AMC MEDICAL RESEARCH BV1
AMGEN1
AMGEN RESEARCH1
ANTAROS MEDICAL AB1
APPLIED RESEARCH USING OMIC SCIENCES SL1
ARLENDA1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS1
ASOCIACION NACIONAL EMPRESARIAL DE LA INDUSTRIA FARMACEUTICA1
ASTRAZENECA UK LIMITED1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
AXXAM1
BARCELONA SUPERCOMPUTING CENTER CENTRO NACIONAL DE SUPERCOMPUTACION1
BAYER PHARMA1
BIOCOMUNICAT1
BIOCYTEX1
BIOMIN HOLDING1
BIOSCI CONSULTING BVBA1
BLUEBIRD BIO INC1
BRENDINN THERAPEUTICS BV1
BRISTOLMYERS SQUIBB COMPANY CORP1
BUDAPEST UNIVERSITY OF TECHNOLOGY AND ECONOMICS1
Constancy:

Total number of partners:475

Partner loyalty:
Frequent Partner: (> 2 projects): 152
Rare Partner: 323

Frequent / Rare Partner Ratio: 0.47

Diversity:

Subjects: Diversity index:0.43
Categories:
Category:No:
INDUSTRY AND TECHNOLOGY1
SOCIAL AND ECONOMIC CONCERNS1

Project overview:

Start dateProjectacronymrolefundingpartners
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00022
2019-12-01Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies imSAVARparticipant10.999.31628
2019-09-01Proton transport and proton-coupled transport PROTONparticipant3.976.97612
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99831
2019-06-01MachinE Learning Ledger Orchestration for Drug DiscoverY MELLODDYparticipant8.000.00017
2019-05-01ENdoThelial macRophage Alliance In Neuroinflammation ENTRAINparticipant3.664.17420
2019-04-01Thrombo-inflammation in cardiovascular disease TICARDIOparticipant3.944.03810
2019-04-01Biomarkers in Atopic Dermatitis and Psoriasis BIOMAPparticipant10.500.00032
2019-01-01A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes Secretersparticipant4.087.42116
2019-01-01FAIRplus FAIRplusparticipant3.996.15022
2018-12-01Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe EUROoCparticipant3.942.86121
2018-07-01Research empowerment on solute carriers (ReSOLUTE) ReSOLUTEparticipant12.000.00014
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-10-01European Quality In Preclinical Data EQIPDparticipant4.495.52330
2017-09-01Targeting the metabolism-immune system connections in Cancer META-CANparticipant3.831.95820
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-02-01Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 DO-ITparticipant3.549.83336
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2016-09-01Biomarker Enterprise to Attack DKD - Sofia ref.: 115974 BEAt-DKDparticipant15.085.93731
2016-04-01Psychiatric Ratings using Intermediate Stratified Markers - Sofia ref.: 115916 PRISMparticipant8.080.00023
2016-03-01Vaccine lot to Vaccine lot comparison by consistancy testing - Sofia ref.: 115924 VAC2VACparticipant7.850.00023
2016-01-01Big Data in Chemistry BIGCHEMparticipant2.540.14617
2013-11-01From DISCOvery to products: A next generation pipeline for the sustainable generation of high-value plant products DISCOparticipant6.485.84715
2012-10-01Interdisciplinary training network for Tourette Syndrome; structuring European Training capacities for neurodevelopmental disorders TS-EUROTRAINparticipant3.076.39810
2012-04-01Mucus Permeating Nanoparticulate Drug Delivery Systems ALEXANDERparticipant8.098.20218
2010-12-01Transport and signalling in Polarized Cells TRANSPOLparticipant3.835.98011
2010-02-01"Development of Vaccines for bTV, EHDV and AHSV" ORBIVACparticipant2.999.72918
2010-01-01New tools and approaches to control Porcine Reproductive and Respiratory Syndrome (PRRS) in the EU and Asia PoRRSConparticipant2.999.07016
2009-11-01Academic-Industrial Training Network on Alpha-Synuclein-related Brain Diseases NEURASYNCparticipant2.419.22710
2008-03-01European stroke research network EUSTROKEparticipant9.953.91517
2008-02-01A sophisticated multi-parametric system for the continuous-effective assessment and monitoring of motor status in Parkinson's disease and other neurodegenerative diseases PERFORMparticipant6.999.99918
2007-03-01Polarized Helium Lung Imaging Network PHELINETparticipant3.702.75017
2005-10-01Innovative medicines for europe INNOMEDparticipant11.998.52742
2004-01-01Platform for wide scale integration and visual representation of medical intelligence NOESIScoordinator4.088.38412
2002-11-16ESTABLISHING A HEALTH COMMUNITY KNOWLEDGE MANAGEMENT SYSTEM HEALTH MEMORYcoordinator2.060.8736

Alias institution names:
  • BOEHRIGER INGELHEIM INTERNATIONAL
  • BOEHRINGER INGELHEIM INTERNATIONALGMBH
  • BOEHRINGER INGELHEIM ITALIA
  • BOEHRINGER INGELHEIM PHARMA GMBH & CO KG
  • BOEHRINGER INGELHEIM PHARMA GMBH &CO KG
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG
  • BOEHRINGER INGELHEIM VETMEDICA

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum